Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 1612948, 11 pages
https://doi.org/10.1155/2018/1612948
Review Article

A Classic Herbal Formula Danggui Beimu Kushen Wan for Chronic Prostatitis: From Traditional Knowledge to Scientific Exploration

1School of Health and Biomedical Sciences, RMIT University, Australia
2School of Science, RMIT University, Australia

Correspondence should be addressed to Angela Wei Hong Yang; ua.ude.timr@gnay.alegna

Received 22 June 2018; Revised 30 September 2018; Accepted 15 October 2018; Published 13 November 2018

Academic Editor: Cheorl-Ho Kim

Copyright © 2018 Hong Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. N. Krieger, S. W. H. Lee, J. Jeon, P. Y. Cheah, M. L. Liong, and D. E. Riley, “Epidemiology of prostatitis,” International Journal of Antimicrobial Agents, vol. 31, no. 1, pp. 85–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Pavone-Macaluso, “Chronic prostatitis syndrome: a common, but poorly understood condition. Part I,” EAU-EBU Update Series, vol. 5, no. 1, pp. 1–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Schaeffer, “Epidemiology and evaluation of chronic pelvic pain syndrome in men,” International Journal of Antimicrobial Agents, vol. 31, no. 1, pp. 108–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. N. Krieger, L. Nyberg, and J. C. Nickel, “NIH consensus definition and classification of prostatitis,” The Journal of the American Medical Association, vol. 282, no. 3, pp. 236-237, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. A. B. Murphy, A. Macejko, A. Taylor, and R. B. Nadler, “Chronic prostatitis,” Drugs, vol. 69, no. 1, pp. 71–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Rees, M. Abrahams, A. Doble, and A. Cooper, “Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline,” BJU International, vol. 116, no. 4, pp. 509–525, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. Andrology Australia, “Prostate disease: BPH and prostatitis-diagnosis and management, clinical summary guide,” 2010.
  8. J. C. Nickel, “Prostatitis,” Canadian Urological Association Journal, vol. 5, no. 5, pp. 306–315, 2011. View at Publisher · View at Google Scholar
  9. I. Cheng, J. S. Witte, S. J. Jacobsen et al., “Prostatitis, sexually transmitted diseases, and prostate cancer: the California men’s health study,” PLoS ONE, vol. 5, no. 1, p. e8736, 2010. View at Publisher · View at Google Scholar
  10. C.-Y. Wang, X.-Y. Bai, and C.-H. Wang, “Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development,” American Journal of Chinese Medicine, vol. 42, no. 3, pp. 543–559, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. China Association of Chinese Medicine, Zhong Hua Yi Dian (Encyclopaedia of traditional Chinese medicine) [CD-ROM], Hunan Electronic and Audio-Visual Publishing House, Changsha, China, 2015.
  12. Q. Zhang, N. Yang, and Y. Chen, “Randomised controlled clinical trials on Danggui Beimu Kushen decoction combined with α-blockers in treatment of type III prostatitis,” Liaoning Journal of Traditional Chinese Medicine, vol. 41, no. 7, pp. 1414–1416, 2014. View at Google Scholar
  13. Y. Xiong, X. Qiu, W. Shi, H. Yu, and X. Zhang, “Anti-inflammatory and antioxidant effect of modified Bazhengsan in a rat model of chronic bacterial prostatitis,” Journal of Ethnopharmacology, vol. 198, pp. 73–80, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Zhang, X. Zeng, Y. Chen, R. Zhao, H. Wang, and J. Wu, “Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  15. D. Wu, “Effects of Danggui Beimu Kushen decoction for the treatment of chronic bacterial prostatitis,” Guide of China Medicine, vol. 9, no. 22, pp. 130-131, 2011. View at Publisher · View at Google Scholar
  16. L. Xi and T. Yao, “50 cases of benign prostatic hyperplasia with modified Danggui Beimu Kushen pills,” Journal of Changchun University of Traditional Chinese Medicine, vol. 23, no. 4, p. 58, 2007. View at Publisher · View at Google Scholar
  17. Y. Li and X. Gao, “Clinical experience from Professor Xixing Wang on Danggui Beimu Kushen Wan for the treatment of malignant tumour,” Shanxi Journal of Traditional Chinese Medicine, vol. 27, no. 12, pp. 4–6, 2011. View at Google Scholar
  18. Z. Zhang, N. Wiseman, and S. Wilms, Jin Gui Yao Lue: Essential prescriptions of the Golden Cabinet, Paradigm Publications, Taos, New Mexico, 2013. View at Publisher · View at Google Scholar
  19. R. Li, Surgery of Chinese Medicine, China Press of Traditional Chinese Medicine, Beijing, China, 2017.
  20. C. Xie, X. Tang, W. Xu et al., “A host defense mechanism involving CFTR-mediated bicarbonate secretion in bacterial prostatitis,” PLoS ONE, vol. 5, no. 12, p. e15255, 2010. View at Publisher · View at Google Scholar
  21. L. R. Sanchez, M. L. Breser, G. J. Godoy et al., “Chronic infection of the prostate by chlamydia muridarum is accompanied by local inflammation and pelvic pain development,” The Prostate, vol. 77, no. 5, pp. 517–529, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Funahashi, T. Majima, Y. Matsukawa, T. Yamamoto, M. Yoshida, and M. Gotoh, “Intraprostatic reflux of urine induces inflammation in a rat,” The Prostate, vol. 77, no. 2, pp. 164–172, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. R. S. Kirby, D. Lowe, M. I. Bultitude, and K. E. D. Shuttleworth, “Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis,” British Journal of Urology, vol. 54, no. 6, pp. 729–731, 1982. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Awad and J. W. Downie, “Sympathetic dyssynergia in the region of the external sphincter: a possible source of lower urinary tract obstruction,” The Journal of Urology, vol. 118, no. 4, pp. 636–640, 1977. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Potts, R. Sharma, F. Pasqualotto, D. Nelson, G. Hall, and A. Agarwal, “Association of Ureaplasma urealyticum with abnormal reactive oxygen species levels and absence of leukocytospermia,” The Journal of Urology, vol. 163, no. 6, pp. 1775–1178, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Hu, X. Niu, G. Wang, J. Huang, M. Liu, and B. Peng, “Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model,” Andrology, vol. 4, no. 6, pp. 1209–1216, 2016. View at Google Scholar · View at Scopus
  27. L. Q. Meng, F. Y. Yang, M. S. Wang et al., “Quercetin protects against chronic prostatitis in rat model through NF-kappaB and MAPK signaling pathways,” Prostate, vol. 78, no. 11, pp. 790–800, 2018. View at Google Scholar
  28. J. Bernoulli, E. Yatkin, E.-M. Talvitie, R. Santti, and T. Streng, “Urodynamic changes in a noble rat model for nonbacterial prostatic inflammation,” The Prostate, vol. 67, no. 8, pp. 888–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. S. Schiller and A. Parikh, “Identification, pharmacologic considerations, and management of prostatitis,” American Journal of Geriatric Pharmacotherapy, vol. 9, no. 1, pp. 37–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Kallenborn-Gerhardt and A. Schmidtko, “A novel signaling pathway that modulates inflammatory pain,” The Journal of Neuroscience, vol. 31, no. 3, pp. 798–800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Bernoulli, E. Yatkin, Y. Konkol, E.-M. Talvitie, R. Santti, and T. Streng, “Prostatic inflammation and obstructive voiding in the adult noble rat: impact of the testosterone to estradiol ratio in serum,” The Prostate, vol. 68, no. 12, pp. 1296–1306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Qi, L. Han, X. Liu et al., “Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome,” Urology, vol. 80, no. 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Doble, M. M. Walker, J. R. Harris, D. Taylor-Robinson, and R. O. Witherow, “Intraprostatic antibody deposition in chronic abacterial prostatitis,” British Journal of Urology, vol. 65, no. 6, pp. 598–605, 1990. View at Publisher · View at Google Scholar · View at Scopus
  34. R. D. Motrich, M. Maccioni, R. Molina et al., “Presence of INFγ-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients,” Clinical Immunology, vol. 116, no. 2, pp. 149–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Maciocia, The foundations of Chinese medicine: A comprehensive text, Elsevier Health Sciences, London, UK, 2015.
  36. K. Aschbacher, A. O'Donovan, O. M. Wolkowitz, F. S. Dhabhar, Y. Su, and E. Epel, “Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity,” Psychoneuroendocrinology, vol. 38, no. 9, pp. 1698–1708, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Bouayed, H. Rammal, and R. Soulimani, “Oxidative stress and anxiety: relationship and cellular pathways,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 2, pp. 63–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. K. H. Al-Gubory, “Environmental pollutants and lifestyle factors induce oxidative stress and poor prenatal development,” Reproductive BioMedicine Online, vol. 29, no. 1, pp. 17–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Knussmann, K. Christiansen, and C. Couwenbergs, “Relations between sex hormone levels and sexual behavior in men,” Archives of Sexual Behavior, vol. 15, no. 5, pp. 429–445, 1986. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Chen, C. Hu, Y. Peng et al., “Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: A case-control study,” Prostate Cancer and Prostatic Diseases, vol. 19, no. 1, pp. 92–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. S. C. Castle, “Clinical relevance of age-related immune dysfunction,” Clinical Infectious Diseases, vol. 31, no. 2, pp. 578–585, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. J. P. T. Higgins and S. Green, “Cochrane handbook for systematic reviews of interventions (Version 5.1.0),” http://handbook-5-1.cochrane.org/, 2011. View at Publisher · View at Google Scholar
  43. B. Guo, “A randomized controlled trial of modified Danggui Beimu Kushen Wan in 85 patients with chronic prostatitis,” Forum on Traditional Chinese Medicine, vol. 23, no. 6, p. 7, 2008. View at Google Scholar
  44. S. Wu, “Clinical effects of chronic prostatitis with Chinese herbal medicine,” Modern Chinese Clinial Medicine, vol. 1, no. 2, pp. 38–40, 1994. View at Google Scholar
  45. G. Li and W. Yan, “Chronic pelvic pain syndrome treated by modified Danggui Beimu Kushen Wan: A report of 45 cases,” Hubei Journal of Traditional Chinese Medicine, vol. 29, no. 6, pp. 36–36, 2007. View at Google Scholar
  46. X. Wang, “Chronic prostatitis treated by modified Danggui Beimu Kushen Wan: a report of 120 cases,” Western Journal of Traditional Chinese Medicine, vol. 20, no. 12, pp. 39-40, 2007. View at Publisher · View at Google Scholar
  47. Chinese Medicine Board of Australia, “Nomenclature list of commonly used Chinese herbal medicines,” http://www.chinesemedicineboard.gov.au/documents/default.aspx?record=WD15%2f18746&dbid=AP&chksum=Cs%2baCFhYVrzbzL2%2bYnhtRA%3d%3d, 2018.
  48. J. Pildal, A. Hróbjartsson, K. J. Jörgensen, J. Hilden, D. G. Altman, and P. C. Gøtzsche, “Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials,” International Journal of Epidemiology, vol. 36, no. 4, pp. 847–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. F. M. E. Wagenlehner, J. W. O. Van Till, V. Magri et al., “National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome,” European Urology, vol. 63, no. 5, pp. 953–959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Jin, Z. Chen, and J. Zhang, “Meta-analysis of the efficacy of Ningmitai capsule on the treatment of chronic prostatitis in China,” Medicine (Baltimore), vol. 97, no. 33, p. e11840, 2018. View at Publisher · View at Google Scholar
  51. C. Huang, J. Xu, and Y. Qiu, “Efficacy and safety of Qianlie Shutong combined with quinolone antibiotics in the treatment of chronic prostatitis: A meta-analysis,” China Pharmacy, vol. 27, no. 6, pp. 793–797, 2016. View at Google Scholar
  52. H. Sun and A. Lyu, “Meta-analysis of compound Xuanju capsule plus antibiotics for treating patients with chronic prostatitis,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 22, no. 11, pp. 194–197, 2016. View at Google Scholar
  53. L. He, Y. Fu, and L. Zhang, “Effects of Danggui Beimu Kushen decoction on ICAM-1 in the prostates of CBP rats,” Journal of Shanxi College of Traditional Chinese Medicine, vol. 13, no. 6, pp. 20-21, 2012. View at Google Scholar
  54. L. He, Y. Fu, and L. Zhang, “Impacts of Danggui Beimu Kushen decoction on prostatic WBC and SPL for the rats with chronic bacterial prostatitis,” World Journal of Integrated Traditional and Western Medicine, vol. 7, no. 12, pp. 1027-1028, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. L. He, Y. Fu, Y. Ma, F. Cao, and X. Liu, “The effects of Danggui Beimu Kushen decoction on TNF-α in prostates in rats with chronic bacterial prostatitis,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, no. 2, pp. 212–214, 2012. View at Publisher · View at Google Scholar
  56. L. He, “Effects of DANGGUIBEIMUKUSHEN decoction on the whole blood viscosity of chronic bacterial prostatic rats,” Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, vol. 23, no. 1, pp. 12-13, 2013. View at Google Scholar
  57. L. He, “The effects of DANGUIBEIMUKUSHEN decoction on IL-1β in the prostates of CBP rats,” Chinese Archives of Traditional Chinese Medicine, vol. 28, no. 7, pp. 1524–1526, 2010. View at Google Scholar
  58. L. He, Y. Fu, Y. Ma, F. Cao, and X. Liu, “The effects of Danggui Beimu Kushen decoction on IL-2 and IL-8 in prostates in rats with chronic bacterial prostatitis,” Chinese Journal of Traditional Medical Science and Technology, vol. 17, no. 6, pp. 505-506, 2010. View at Google Scholar
  59. L. He, Y. Fu, and L. Zhang, “The effects of Danggui Beimu Kushen decoction on DHT in the prostates of CBP rats,” Guangming Traditional Chinese Medicine, vol. 28, no. 3, pp. 483-484, 2013. View at Publisher · View at Google Scholar
  60. L. He, Y. Fu, Y. Ma, F. Cao, and X. Liu, “Effects of Danggui Beimu Kushen decoction on the contents of SOD and MDA in prostate of CBP rats,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 17, no. 9, pp. 28-29, 2010. View at Google Scholar
  61. D. Yan, Y. Liu, Y. Li et al., “Tumor-inhibitory role of Danggui Beimu Kushen Pills in cisplatin chemotherapy to H22 tumor-bearing mice and effect on serum levels of HIF-1α and LDH,” Chinese Traditional Patent Medicine, vol. 36, no. 11, pp. 1351–1355, 2014. View at Publisher · View at Google Scholar
  62. Y. M. Choy, K. N. Leung, C. S. Cho, C. K. Wong, and P. K. Pang, “Immunopharmacological studies of low molecular weight polysaccharide from Angelica sinensis,” American Journal of Chinese Medicine, vol. 22, no. 2, pp. 137–145, 1994. View at Publisher · View at Google Scholar · View at Scopus
  63. C.-Y. Cheng, T.-Y. Ho, E.-J. Lee, S.-Y. Su, N.-Y. Tang, and C.-L. Hsieh, “Ferulic acid reduces cerebral infarct through its antioxidative and anti-Inflammatory effects following transient focal cerebral ischemia in rats,” American Journal of Chinese Medicine, vol. 36, no. 6, pp. 1105–1119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. J.-R. Du, Y. Yu, Y. Yao et al., “Ligustilide reduces phenylephrine induced-aortic tension in vitro but has no effect on systolic pressure in spontaneously hypertensive rats,” American Journal of Chinese Medicine, vol. 35, no. 3, pp. 487–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Y. Huang and C. X. Chen, “Effect of oxymatrine, the active component from Radix Sophorae flavescentis (Kushen), on ventricular remodeling in spontaneously hypertensive rats,” Phytomedicine, vol. 20, no. 3-4, pp. 202–212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. J.-Z. Song, H.-X. Xu, S.-J. Tian, and P. P.-H. But, “Determination of quinolizidine alkaloids in traditional Chinese herbal drugs by nonaqueous capillary electrophoresis,” Journal of Chromatography A, vol. 857, no. 1-2, pp. 303–311, 1999. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Duan, L. Huang, and S. Chen, “Study on the destructive effect to inherent quality of Fritillaria thunbergii Miq. (Zhebeimu) by sulfur-fumigated process using chromatographic fingerprinting analysis,” Phytomedicine, vol. 19, no. 6, pp. 562–568, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. G. R. Zimmermann, J. Lehár, and C. T. Keith, “Multi-target therapeutics: when the whole is greater than the sum of the parts,” Drug Discovery Therapy, vol. 12, no. 1-2, pp. 34–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. H.-T. Xiao, L. Zhong, S.-W. Tsang, Z.-S. Lin, and Z.-X. Bian, “Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings,” American Journal of Chinese Medicine, vol. 43, no. 1, pp. 1–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. S. B. Meropol, K. A. Chan, Z. Chen et al., “Adverse events associated with prolonged antibiotic use,” Pharmacoepidemiology and Drug Safety, vol. 17, no. 5, pp. 523–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. J. J. De La Rosette, B. B. Kortmann, C. Rossi, G. S. Sonke, D. L. Floratos, and L. A. Kiemeney, “Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms,” The Journal of Urology, vol. 167, no. 4, pp. 1734–1739, 2002. View at Publisher · View at Google Scholar
  72. W. H. Hörl, “Nonsteroidal anti-inflammatory drugs and the kidney,” Pharmaceuticals, vol. 3, no. 7, pp. 2291–2321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. A. M. Traish, R. C. Melcangi, M. Bortolato, L. M. Garcia-Segura, and M. Zitzmann, “Adverse effects of 5alpha-reductase inhibitors: What do we know, don't know, and need to know?” Reviews in Endocrine and Metabolic Disorders, vol. 16, no. 3, pp. 177–198, 2015. View at Publisher · View at Google Scholar